Viemed director settles awards, returns 3,757 shares
For VIEMED HEALTHCARE, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
For VIEMED HEALTHCARE, INC. (VMD), director Timothy Smokoff reported several equity compensation events. On August 19, 2026, previously granted Restricted Stock Units and Phantom Share Units vested and were exercised or settled into a total of common shares, with 3,757 common shares then returned to the company in a disposition at $8.94 per share. Separately, on August 17, 2026, he received new grants of 12,174 Restricted Stock Units and 3,043 Phantom Share Units, each convertible into an equal number of common shares and scheduled to vest on the first anniversary of the grant date. These transactions were not reported as made under a Rule 10b5-1 trading plan.
Insider Trade Summary
18,786 shares exercised/converted
Exercise
7 txns
Insider
Smokoff Timothy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F4 | 15,029 | $0.00 | $0.00 |
| Exercise | Phantom Share Units F2, F5 | 3,757 | $0.00 | $0.00 |
| Exercise | Common Shares F1 | 15,029 | -- | -- |
| Exercise | Common Shares F2 | 3,757 | -- | -- |
| Disposition | Common Shares F3 | 3,757 | $8.94 | $34K |
| Grant/Award | Restricted Stock Units F1, F6 | 12,174 | $0.00 | $0.00 |
| Grant/Award | Phantom Share Units F7, F8 | 3,043 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 12,174 contracts (Direct);
Phantom Share Units — 3,043 contracts (Direct);
Common Shares — 90,547 shares (Direct)
Footnotes (8)
- F1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
- F2. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
- F3. Per share value is based on the market closing price of the common shares for August 19, 2026.
- F4. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
- F5. On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
- F6. Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.
- F7. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
- F8. Represents an award granted on August 17, 2026 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.
Key Figures
RSUs exercised into common shares: 15,029 shares
Phantom Share Units settled: 3,757 units
Common shares returned to issuer: 3,757 shares at $8.94 per share
+5 more
8 metrics
RSUs exercised into common shares
15,029 shares
Restricted Stock Units converted into common shares on August 19, 2026
Phantom Share Units settled
3,757 units
Cash-settled phantom shares settled on August 19, 2026, economically equivalent to common shares
Common shares returned to issuer
3,757 shares at $8.94 per share
Disposition of common shares to Viemed Healthcare on August 19, 2026
New RSU grant
12,174 units
Restricted Stock Units granted on August 17, 2026, vesting on first anniversary
New Phantom Share Unit grant
3,043 units
Phantom Share Units granted on August 17, 2026, vesting on first anniversary
Total derivative exercise shares
18,786 shares
Aggregate underlying shares from derivative exercises (RSUs and phantom units) reported
RSU expiration date
2027-08-17
Expiration/vesting-related date for new RSU grant reported as 2027-08-17
Phantom Share Unit expiration date
2027-08-17
Expiration/vesting-related date for new Phantom Share Unit grant reported as 2027-08-17
Key Terms
Restricted Stock Units, Phantom Share Units, cash-settled phantom shares, disposition to issuer
4 terms
Restricted Stock Units financial
"Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
disposition to issuer financial
"Common Shares transaction code D ... transaction_action issuer disposition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Timothy Smokoff report for VMD on August 19, 2026?
Timothy Smokoff reported exercising RSUs and settling Phantom Share Units into common shares, then returning 3,757 shares to Viemed Healthcare in a disposition at $8.94 per share, as part of equity award vesting and settlement activity.
How many new Restricted Stock Units were granted to Timothy Smokoff by VMD in August 2026?
On August 17, 2026, Timothy Smokoff received a grant of 12,174 Restricted Stock Units. Each RSU represents a contingent right to receive one common share and vests on the first anniversary of the grant date, subject to the plan terms.
Were Timothy Smokoff’s August 2026 VMD transactions under a Rule 10b5-1 plan?
The Form 4 indicates the transactions were not reported as being made under a Rule 10b5-1 trading plan. The document-level checkbox affirming Rule 10b5-1 status was not selected for these transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
